吸入海洛因在阿片类 epidemic 中的新兴作用:综述
本文综述吸入海洛因(追龙,CTD)的药理学、病理生理学、临床谱、神经影像与神经病理,指出其独特地导致侵袭性中毒性白质脑病并伴特征性神经病理改变,偶见运动障碍与脑积水;临床表现入院时多为中度、出院时多无变化、长期多改善,中重度可恶化至死亡,并提出诊断标准与标准化报告以推进辅酶Q10治疗试验。
要点
- 吸入海洛因(追龙)可导致具特征性神经病理表现的侵袭性中毒性白质脑病。
- 临床严重度入院时以中度为主,出院时多无变化,长期多改善。
- 作者提出诊断标准与标准化报告,以促进辅酶Q10治疗试验的患者选择。
核心结论
- 吸入海洛因(追龙)的药理学特征与其特定临床和影像学表现相关,并引发对潜在发病率与长期残疾成本的严重关切。
- 作者提出诊断标准与标准化报告可改善追龙(CTD)文献的局限性,并促进辅酶Q10治疗试验的患者选择。
研究设计与样本
- 本文为综述,围绕吸入海洛因(追龙,CTD)的药理学、病理生理学、临床谱、神经影像与神经病理进行描述,并与其他海洛因滥用方式相区分。
主要发现
- 追龙(CTD)相关健康结局包括具特征性神经病理特征的侵袭性中毒性白质脑病,以及散发的运动障碍与脑积水病例。
- 临床CTD严重度入院时以中度为主,出院时多无变化,长期多改善;轻度病例存活并遗留轻微后遗症,中度至重度表现可能恶化并进展至死亡。
- 其他海洛因使用方式可能并发卒中、癫痫发作、梗阻性脑积水以及(非典型地)白质脑病。
- 与鼻吸或嗅吸相比,加热海洛因吸入其烟雾的方式具有更高可及性、更易给药和更强的主观体验强度,但与注射相比具有更安全的感染特征。
临床怎么用
- 作者提出诊断标准与标准化报告可改善追龙(CTD)文献的局限性,并促进辅酶Q10治疗试验的患者选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Opioid addiction affects approximately 2.4 million Americans. Nearly 1 million individuals, including a growing subset of 21 000 minors, abuse heroin. Its annual cost within the United States amounts to $51 billion. Inhaled heroin use represents a global phenomenon and is approaching epidemic levels east of the Mississippi River as well as among urban youth. Chasing the dragon (CTD) by heating heroin and inhaling its fumes is particularly concerning, because this method of heroin usage has greater availability, greater ease of administration, and impressive intensity of subjective experience (high) compared with sniffing or snorting, although it also has a safer infectious profile compared with heroin injection. This is relevant owing to peculiar and often catastrophic brain complications. Following the American Medical Association Opioid Task Force mandate, we contribute a description of the pharmacology, pathophysiology, clinical spectrum, neuroimaging, and neuropathology of CTD leukoencephalopathy, as distinct from other heroin abuse modalities. OBSERVATIONS: The unique spectrum of CTD-associated health outcomes includes an aggressive toxic leukoencephalopathy with pathognomonic neuropathologic features, along with sporadic instances of movement disorders and hydrocephalus. Clinical CTD severity is predominantly moderate at admission, frequently unmodified at discharge, and largely improved in the long term. Mild cases survive with minor sequelae, while moderate to severe presentations might deteriorate and progress to death. Other methods of heroin use may complicate with stroke, seizure, obstructive hydrocephalus, and (uncharacteristically) leukoencephalopathy. CONCLUSIONS AND RELEVANCE: The distinct pharmacology of CTD correlates with its specific clinical and radiological features and prompts grave concern for potential morbidity and long-term disability costs. Proposed diagnostic criteria and standardized reporting would ameliorate the limitations of CTD literature and facilitate patient selection for a coenzyme Q10 therapeutic trial.
引用
- Alambyan V, Pace J, Miller B, et al. The Emerging Role of Inhaled Heroin in the Opioid Epidemic: A Review. JAMA Neurol. 2018. PMID: 29987325. doi:10.1001/jamaneurol.2018.1693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。